Results 211 to 220 of about 8,561,878 (291)

Dental Coverage Through Medicaid Managed Care vs Fee-for-Service.

JAMA Health Forum
Elani HW, Zhao N, Wallace J, Sommers BD.
europepmc   +1 more source

Influence of Livelihood Strategies on Local People Perception Toward the Benefits and Cost of Community-Based Natural Resource Management: A Case of Burunge Wildlife Management Area, Tanzania. [PDF]

Ecol Evol
Kegamba JJ, Melembuki AS, Kyaruzi JJ.
europepmc   +1 more source

Visual Recovery Reflects Cortical MeCP2 Sensitivity in Rett Syndrome

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rett syndrome (RTT) is a devastating neurodevelopmental disorder with developmental regression affecting motor, sensory, and cognitive functions. Sensory disruptions contribute to the complex behavioral and cognitive difficulties and represent an important target for therapeutic interventions.
Alex Joseph Simon, Nathalie Picard, Valeria d'Andrea, Enchi Chang, Joseph Leffler, Eleonora Centofante, Matthew Taylor, Francesca Bardi, Francesca Cavicchiolo, Takao K. Hensch, Stefano Panzeri, Chinfei Chen, Michela Fagiolini   +12 more
wiley   +1 more source

Leveraging the Translational Science Benefits Model to plan and measure early impact in the heart failure polypill implementation trial in Sri Lanka. [PDF]

J Clin Transl Sci
Hively A, La Manna A, Clark E, Luke D, de Silva A, Agarwal M, Huffman MD, Salam A, Agarwal A, Tetteh EK.   +9 more
europepmc   +1 more source

The William & Mary Law School Lewis B. Puller, Jr. Veterans Benefits Clinic and HMVHE News (Vol. 1, Issue 1)

, 2012
Lewis B. Puller, Jr. Veterans Benefits Clinic
core  

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Exploring differences in health-related benefit status in the year before, during and after specialist rehabilitation: a Norwegian case-control study. [PDF]

BMJ Open
Skinnes MN, Uhlig T, Johansen T, Morvik HK, Farsund N, Fossen J, Skardal RF, Tollin G, Degirmenci AET, Habberstad A, Sexton J, Kollerud R, Kjeken I, RehabNytte Consortium, Wilkie R, Moe RH.   +15 more
europepmc   +1 more source

Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke: A Multicenter Prospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai, Yang Qu, Reziya Abuduxukuer, Kejia Zhang, Peng Zhang, Xin Tang, Huaimei Zhang, Lijuan Wang, Lichong Yang, Shuangxu Tan, Zhimei Yuan, Ce Han, Lili He, Yuping Zheng, Fenglan Zhao, Lijie Guo, Ligang Jiang, Jinfeng Li, Yongfei Jiang, Xuexia Zou, Dan Xu, Han Xu, Xiaojia Wang, Yingbin Qi, Xuefeng Hu, Yu Zhang, Zhen‐Ni Guo, Hang Jin, on behalf of the Biomarkers of Brain Injury Investigator Study Group   +28 more
wiley   +1 more source